Empower Clinic Inc said it has entered a memorandum of understanding (MOU) with Pharmasave for a six-month pilot program to distribute and resell its Kai coronavirus (COVID-19) Testing Solutions at independent pharmacies.
Empower said the products will include Rapid Antigen Testing, Rapid Antibody Testing and Kai Saliva RT-PCR tests.
Pharmasave is one of Canada’s leading independent pharmacy and drugstore retailers, with over 800 stores across the country. Under the six-month pilot program, both companies will evaluate the costs and revenue opportunities while determining a final business model that will serve Pharmasave’s patients and their corporate accounts.
Empower will provide Pharmsave with Health Canada Approved COVID-19 Testing Solutions, express shipping on all ordered units, and technical support.
READ: Empower Clinics' MediSure gets Health Canada Medical Device Establishment Licence to source medical devices globally
"Tapping into Pharmasave's network is a huge step forward in our plan to provide Kai Testing Solutions directly to consumers and further our national clinic expansion strategy,” Empower chairman and CEO Steven McAuley said in a statement.
"With corporate pharmacy partners, PharmaChoice and now Pharmasave, we are seeing steady growth and momentum with a number of pharmacy groups from across North America,” he added.
The company said it hopes to build on the partnership with Pharmasave through its national clinic expansion strategy and increase the number of services readily available to Canadians.
Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, and world-class medical diagnostics laboratories. It is aggressively growing its clinical and digital presence across North America.
Empower’s Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of its patients.
Contact the author at stephen.gunnion@proactiveinvestors.com